120 related articles for article (PubMed ID: 20417098)
1. Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists.
Rotstein DM; Melville CR; Padilla F; Cournoyer D; Lee EK; Lemoine R; Petersen AC; Setti LQ; Wanner J; Chen L; Filonova L; Loughhead DG; Manka J; Lin XF; Gleason S; Sankuratri S; Ji C; Derosier A; Dioszegi M; Heilek G; Jekle A; Berry P; Mau CI; Weller P
Bioorg Med Chem Lett; 2010 May; 20(10):3116-9. PubMed ID: 20417098
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacycles.
Lemoine RC; Petersen AC; Setti L; Wanner J; Jekle A; Heilek G; deRosier A; Ji C; Berry P; Rotstein D
Bioorg Med Chem Lett; 2010 Jan; 20(2):704-8. PubMed ID: 20004099
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): modification of the acyl portion.
Duan M; Peckham J; Edelstein M; Ferris R; Kazmierski WM; Spaltenstein A; Wheelan P; Xiong Z
Bioorg Med Chem Lett; 2010 Dec; 20(24):7401-4. PubMed ID: 21055933
[TBL] [Abstract][Full Text] [Related]
4. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists.
Ernst J; Dahl R; Lum C; Sebo L; Urban J; Miller SG; Lundström J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1498-501. PubMed ID: 18194864
[TBL] [Abstract][Full Text] [Related]
6. Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): optimization of the amine portion.
Duan M; Peckham J; Edelstein M; Ferris R; Kazmierski WM; Spaltenstein A; Wheelan P; Xiong Z
Bioorg Med Chem Lett; 2010 Dec; 20(24):7397-400. PubMed ID: 21035337
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.
Shu M; Loebach JL; Parker KA; Mills SG; Chapman KT; Shen DM; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Salvo JD; Lyons K; Pivnichny JV; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
Bioorg Med Chem Lett; 2004 Feb; 14(4):947-52. PubMed ID: 15012999
[TBL] [Abstract][Full Text] [Related]
8. CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives.
Wei RG; Arnaiz DO; Chou YL; Davey D; Dunning L; Lee W; Lu SF; Onuffer J; Ye B; Phillips G
Bioorg Med Chem Lett; 2007 Jan; 17(1):231-4. PubMed ID: 17081751
[TBL] [Abstract][Full Text] [Related]
9. Spiropiperidine CCR5 antagonists.
Rotstein DM; Gabriel SD; Makra F; Filonova L; Gleason S; Brotherton-Pleiss C; Setti LQ; Trejo-Martin A; Lee EK; Sankuratri S; Ji C; Derosier A; Dioszegi M; Heilek G; Jekle A; Berry P; Weller P; Mau CI
Bioorg Med Chem Lett; 2009 Sep; 19(18):5401-6. PubMed ID: 19674898
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
Meanwell NA; Wallace OB; Wang H; Deshpande M; Pearce BC; Trehan A; Yeung KS; Qiu Z; Wright JJ; Robinson BA; Gong YF; Wang HG; Spicer TP; Blair WS; Shi PY; Lin PF
Bioorg Med Chem Lett; 2009 Sep; 19(17):5136-9. PubMed ID: 19632112
[TBL] [Abstract][Full Text] [Related]
11. Exploration of a new series of CCR5 antagonists: multi-dimensional optimization of a sub-series containing N-substituted pyrazoles.
Lemoine RC; Petersen AC; Setti L; Jekle A; Heilek G; deRosier A; Ji C; Berry P; Rotstein DM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4753-6. PubMed ID: 20643548
[TBL] [Abstract][Full Text] [Related]
12. 4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents.
Duan M; Aquino C; Dorsey GF; Ferris R; Kazmierski WM
Bioorg Med Chem Lett; 2009 Sep; 19(17):4988-92. PubMed ID: 19664920
[TBL] [Abstract][Full Text] [Related]
13. Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket.
Stewart KD; Huth JR; Ng TI; McDaniel K; Hutchinson RN; Stoll VS; Mendoza RR; Matayoshi ED; Carrick R; Mo H; Severin J; Walter K; Richardson PL; Barrett LW; Meadows R; Anderson S; Kohlbrenner W; Maring C; Kempf DJ; Molla A; Olejniczak ET
Bioorg Med Chem Lett; 2010 Jan; 20(2):612-7. PubMed ID: 20004576
[TBL] [Abstract][Full Text] [Related]
14. The discovery of tropane-derived CCR5 receptor antagonists.
Armour DR; de Groot MJ; Price DA; Stammen BL; Wood A; Perros M; Burt C
Chem Biol Drug Des; 2006 Apr; 67(4):305-8. PubMed ID: 16629828
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maraviroc.
Lemoine RC; Petersen AC; Setti L; Baldinger T; Wanner J; Jekle A; Heilek G; deRosier A; Ji C; Rotstein DM
Bioorg Med Chem Lett; 2010 Mar; 20(5):1674-6. PubMed ID: 20137937
[TBL] [Abstract][Full Text] [Related]
17. Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.
Kim D; Wang L; Hale JJ; Lynch CL; Budhu RJ; Maccoss M; Mills SG; Malkowitz L; Gould SL; DeMartino JA; Springer MS; Hazuda D; Miller M; Kessler J; Hrin RC; Carver G; Carella A; Henry K; Lineberger J; Schleif WA; Emini EA
Bioorg Med Chem Lett; 2005 Apr; 15(8):2129-34. PubMed ID: 15808483
[TBL] [Abstract][Full Text] [Related]
18. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.
Shen DM; Shu M; Mills SG; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
Bioorg Med Chem Lett; 2004 Feb; 14(4):935-9. PubMed ID: 15012997
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1.
Tallant MD; Duan M; Freeman GA; Ferris RG; Edelstein MP; Kazmierski WM; Wheelan PJ
Bioorg Med Chem Lett; 2011 Mar; 21(5):1394-8. PubMed ID: 21292480
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats.
Duan M; Kazmierski WM; Chong PY; Deanda F; Edelstein M; Ferris R; Peckham J; Wheelan P; Xiong Z; Zhang H; Nishizawa R; Takaoka Y
Bioorg Med Chem Lett; 2011 Nov; 21(21):6470-5. PubMed ID: 21920742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
